Tenderwize
Back to tender search

Open-house framework agreement for Aripiprazole depot injection suspension

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Jul 03, 2027 · 321 days left·Open·Supplies·Framework
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Aripiprazol in der Darreichungsform Depot-Injektionssuspension, ATC N05AX12 (Kopie)

56/100

Opportunity Score

Needs reviewMedium complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

56 / 100

Complexity

48 / 100

Risk factors

Contract documents must be submitted through the DTVP communication area, not the offer area; wrong channel could jeopa...

The last possible date for contract conclusion is 2027-07-03, and monthly start dates depend on the 3rd of the month cu...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Aug 2027
  • Non-exclusive pharmaceutical rebate agreements for Aripiprazole depot injection suspension (ATC N05AX12).
  • Framework/open-house arrangement under § 130a(8) SGB V, with identical, non-individually negotiable contract terms.
Show full summary

Open-house supply arrangement for Aripiprazole depot injection suspension (ATC N05AX12) in Germany, led by AOK Bayern. The model is non-exclusive and open to all pharmaceutical companies that meet the stated self-declared reliability requirement. No contract value is provided. Submission is via DTVP or by signed paper originals; the deadline for contracts starting on the next month begins on the 3rd of the previous month, and the final contract conclusion date is 2027-07-03.

Risks

Contract documents must be submitted through the DTVP communication area, not the offer area; wrong channel could jeopa...

The last possible date for contract conclusion is 2027-07-03, and monthly start dates depend on the 3rd of the month cu...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • The signatory's authority must be evidenced by the commercial register excerpt; otherwise a power of attorney is required.

Eligibility

  • Only pharmaceutical companies are eligible as potential contractual partners.

Administrative

  • Submit the completed and signed contract, completed and signed Annex 'Festlegung der vertragsgegenständlichen Arzneimittel', and completed and signed self-declaration on...

Buyer

Location

München, DEU

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open-house framework agreement for Aripiprazole depot injection suspension

Lot 1 covers non-exclusive open-house rebate agreements for Aripiprazole in depot injection suspension form (ATC N05AX12). The notice states this is an open-house model, not a competitive open procedure, and contracts are offered on identical, non-negotiable terms to qualifying pharmaceutical companies. The lot is sourced from structured data and XML notice.

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

Aug 2025 - Aug 2027

Category

Pharmaceutical products

Deadline

Deadline Jul 03, 2027

Procurement Details

Publication date
24 Jul 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
488809-2025

Documents (2)

Similar tenders